Mizuho Has Lowered Expectations for Vital Farms (NASDAQ:VITL) Stock Price

Vital Farms (NASDAQ:VITL) had its price target lowered by stock analysts at Mizuho from $48.00 to $40.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 97.04% from the stock’s current price.

A number of other analysts have also weighed in on VITL. Morgan Stanley restated an “equal weight” rating and issued a $24.00 target price (down from $45.00) on shares of Vital Farms in a research note on Friday, February 27th. Telsey Advisory Group decreased their price objective on shares of Vital Farms from $50.00 to $35.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Needham & Company LLC restated a “buy” rating and issued a $45.00 price objective on shares of Vital Farms in a research report on Friday, January 30th. TD Cowen reiterated a “buy” rating on shares of Vital Farms in a research report on Tuesday, January 20th. Finally, Zacks Research cut shares of Vital Farms from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 14th. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $45.00.

Vital Farms Stock Up 0.9%

Shares of NASDAQ:VITL opened at $20.30 on Monday. The company’s fifty day moving average is $28.10 and its 200-day moving average is $35.59. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.61 and a current ratio of 2.16. Vital Farms has a 52 week low of $19.75 and a 52 week high of $53.13. The company has a market capitalization of $909.44 million, a PE ratio of 14.10 and a beta of 1.14.

Vital Farms (NASDAQ:VITL) last posted its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03). Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. The firm had revenue of $213.55 million during the quarter, compared to the consensus estimate of $212.83 million. During the same quarter last year, the firm posted $0.23 EPS. The business’s revenue was up 28.6% on a year-over-year basis. Equities research analysts predict that Vital Farms will post 1.11 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Russell Diez-Canseco sold 16,734 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $35.05, for a total transaction of $586,526.70. Following the completion of the sale, the chief executive officer directly owned 649,684 shares of the company’s stock, valued at $22,771,424.20. The trade was a 2.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Matthew Ohayer sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $27.91, for a total transaction of $558,200.00. Following the completion of the transaction, the insider directly owned 6,341,190 shares in the company, valued at approximately $176,982,612.90. The trade was a 0.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 66,734 shares of company stock valued at $2,092,227. 21.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Vital Farms

Several hedge funds have recently added to or reduced their stakes in VITL. Royal Bank of Canada grew its position in shares of Vital Farms by 89.2% during the 1st quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after buying an additional 9,136 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Vital Farms by 5.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after acquiring an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Vital Farms by 3.3% during the first quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock valued at $12,658,000 after purchasing an additional 13,397 shares during the period. Woodline Partners LP bought a new stake in Vital Farms in the first quarter valued at approximately $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Vital Farms by 1.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock worth $2,739,000 after purchasing an additional 1,198 shares during the period. Institutional investors and hedge funds own 98.59% of the company’s stock.

Vital Farms News Summary

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Needham cut its price target from $45 to $35 but maintained a Buy rating, highlighting substantial upside from current levels and signaling continued conviction from that shop. Needham Lowers PT to $35
• Positive Sentiment: Mizuho lowered its target from $48 to $40 but kept an Outperform rating, implying they still see long-term upside despite cutting near-term assumptions. Mizuho Lowers PT to $40
• Positive Sentiment: Several outlets report a consensus analyst view of a “Moderate Buy,” which may support buying interest from investors who focus on the street’s average stance rather than individual downgrades. Analyst Consensus: Moderate Buy
• Neutral Sentiment: Morgan Stanley reiterated an Equal Weight rating, reflecting a neutral view that could temper volatility from more bullish or bearish shops. Morgan Stanley Equal Weight
• Neutral Sentiment: Market commentary is exploring whether the share-price slump creates a buying opportunity after recent weakness; such think-pieces can bring opportunistic buyers but don’t change fundamentals. Has VITL Become More Attractive?
• Negative Sentiment: Benchmark downgraded Vital Farms to Hold from Buy and removed its price target, citing a “volatile” Q1 outlook and tempered FY26 revenue growth — a direct reason for near‑term investor caution. Benchmark Downgrade to Hold
• Negative Sentiment: Rosen Law Firm announced an investigation into potential securities claims alleging Vital Farms may have issued materially misleading information; class‑action inquiries can increase downside risk (legal costs, distraction, sentiment hit). Rosen Law Firm PR Newswire GlobeNewswire

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.